...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
【24h】

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

机译:未选择的尼日利亚乳腺癌患者中BRCA1和BRCA2突变的高患病率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Inherited mutations in the BRCA1 and BRCA2 genes are the strongest genetic predictors of breast cancer and are the primary causes of familial breast/ovarian cancer syndrome. The frequency, spectrum and penetrance of mutant BRCA1/BRCA2 alleles have been determined for several populations, but little information is available for populations of African ancestry, who suffer a disproportionate burden of early onset breast cancer. We have performed complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria. In contrast to previous suggestions that BRCA1/BRCA2 mutation frequencies are low or undetectable in African American populations, we find that Nigerian breast cancer patients have an exceptionally high frequency of BRCA1 and BRCA2 mutations (7.1 and 3.9%, respectively). Sixteen different BRCA1 mutations were detected, seven of which have never been reported previously, while thirteen different BRCA2 mutations were seen, six of which were previously unreported. Thus, our data support enrichment for genetic risk factors in this relatively young cohort. To improve breast cancer outcomes, we suggest that family-based models of risk assessment and genetic counseling coupled with interventions to reduce breast cancer risk should be broadly disseminated in Nigeria and other underserved and understudied populations.
机译:BRCA1和BRCA2基因中的遗传突变是乳腺癌的最强遗传预测因子,并且是家族性乳腺癌/卵巢癌综合征的主要原因。已经确定了几个人群的突变BRCA1 / BRCA2等位基因的频率,谱图和渗透率,但是对于非洲血统的人群而言,他们掌握的信息不多,因为非洲血统的人罹患早期乳腺癌的负担不成比例。我们已经对来自尼日利亚伊巴丹大学医院的434名尼日利亚乳腺癌患者的所有BRCA1和BRCA2外显子和内含子-外显子边界进行了完整的序列分析。与先前提出的在非裔美国人人群中BRCA1 / BRCA2突变频率较低或无法检测到的建议相反,我们发现尼日利亚乳腺癌患者的BRCA1和BRCA2突变频率异常高(分别为7.1%和3.9%)。检测到16种不同的BRCA1突变,其中7种以前从未报道过,而13种不同的BRCA2突变被发现,其中6种以前未报道。因此,我们的数据支持在这个相对年轻的人群中遗传风险因素的丰富化。为了改善乳腺癌的预后,我们建议在尼日利亚和其他服务水平低下且研究不足的人群中广泛传播基于家庭的风险评估和遗传咨询模型,以及降低乳腺癌风险的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号